Aikium is Unlocking the Undruggable Proteome

Using the Worlds First AI-Powered Trillion-Molecule Screening

Yotta-ML²: Where AI Meets the Proteome

Screening AI-designed ultra-large libraries with unprecedented precision

  • Unmatched Scale: 1,000x library capacity vs. traditional methods

  • Target-Agnostic: From G protein-coupled receptors (GPCRs) to Ion Channels and beyond

  • Rapid Development: Achieving therapeutic breakthroughs in months, not years

Yotta-ML2

Deep Learning Engine
1011

Synthetic Biology Platform
1013

Yotta-ML2 the platform that enables Yotta-scale (1024) machine learning (ML) on massive libraries by combining the world’s only AI-Driven trillion-protein mRNA display for large proteins and patented generative AI based on protein language models

Proprietary Models

Why we are Different

  • Binders to Differentiated Regions: Targeting areas antibodies and small molecules cannot

  • High-Impact Partnerships: Collaborating with leading pharma and academic institutions

  • Proven Team: Leaders from NVIDIA, Harvard, 10X Genomics, NIH and the Wyss Institute

Investors

Aikium is Calling!
Join the foundational team pioneering a transformative platform with the power to shape the future of medicine. Together, we aim to deliver 100 breakthrough therapies within the next decade.